These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 20695055)
1. Transparent reaction. Suppliers oppose FDA move to disclose more data. Rhea S Mod Healthc; 2010 Jul; 40(30):16. PubMed ID: 20695055 [No Abstract] [Full Text] [Related]
2. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557 [No Abstract] [Full Text] [Related]
3. Foreign establishment registration and listing. Final rule. Food and Drug Administration, HHS Fed Regist; 2001 Nov; 66(228):59138-61. PubMed ID: 11776289 [TBL] [Abstract][Full Text] [Related]
4. Upon closer inspection. As the U.S. imports more drugs and devices, the FDA's overseas initiatives aim to head off trouble at the source. Rhea S Mod Healthc; 2009 Mar; 39(13):28-30. PubMed ID: 19405431 [No Abstract] [Full Text] [Related]
5. Pharmaceuticals and medical devices: FDA oversight. Chaps NA Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718 [No Abstract] [Full Text] [Related]
6. The impact of FDA reform. Trunzo J Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699 [TBL] [Abstract][Full Text] [Related]
7. Confidentiality laws and secrecy in medical research: improving public access to data on drug safety. Kesselheim AS; Mello MM Health Aff (Millwood); 2007; 26(2):483-91. PubMed ID: 17339677 [TBL] [Abstract][Full Text] [Related]
8. Members of new FDA board tied to industry. Finkelstein JB J Natl Cancer Inst; 2008 Mar; 100(5):296-7. PubMed ID: 18314467 [No Abstract] [Full Text] [Related]
9. ISO 9000. Policy implications for FDA. Taking the pulse of increasing global use of the ISO series of uniform quality standards by FDA regulated industries. Schwemer WL; Lynch MA J Parenter Sci Technol; 1993; 47(3):101-18. PubMed ID: 8360802 [No Abstract] [Full Text] [Related]
10. Trying times at the FDA--the challenge of ensuring the safety of imported pharmaceuticals. Schweitzer SO N Engl J Med; 2008 Apr; 358(17):1773-7. PubMed ID: 18434648 [No Abstract] [Full Text] [Related]
11. Pro-free enterprise group challenges FDA's authority to regulate drug companies' speech. Skolnick AA JAMA; 1994 Feb; 271(5):332, 335. PubMed ID: 8283568 [No Abstract] [Full Text] [Related]
12. Remarks delivered at the Food and Drug Law Institute's 48th Annual Conference. Enzi MB Food Drug Law J; 2005; 60(2):103-6. PubMed ID: 16097090 [No Abstract] [Full Text] [Related]
13. The outer limits of FDA inspections. Scarlett T J Parenter Sci Technol; 1991; 45(4):204-8. PubMed ID: 1770416 [No Abstract] [Full Text] [Related]
14. Pharmaceuticals: drug importation--2005. End of Year Issue Brief. Varma P; Seay M Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708457 [No Abstract] [Full Text] [Related]
15. Europe and FDA agree to limited inspections. Fox JL Nat Biotechnol; 1997 Aug; 15(8):714-5. PubMed ID: 9333519 [No Abstract] [Full Text] [Related]
16. FDA considering new rules that may clamp down on early showings of works in progress. Wagner M Mod Healthc; 1992 Aug; 22(32):34. PubMed ID: 10119785 [No Abstract] [Full Text] [Related]
17. Getting the bad news about your artificial heart valve. Fielder JH Hastings Cent Rep; 1993; 23(2):22-8. PubMed ID: 8463086 [No Abstract] [Full Text] [Related]
18. Ignore FDA reform at your peril. Fulton A AHIP Cover; 2007; 48(4):8, 54. PubMed ID: 17713032 [No Abstract] [Full Text] [Related]
19. Truth in testing laws: a shot in the arm for designer gene tests. van Voorhees A Health Matrix Clevel; 2006; 16(2):797-829. PubMed ID: 16948256 [No Abstract] [Full Text] [Related]